Article
Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan.
Familial cancer - 1 Jan 2023
Rashid Muhammad Usman, Muhammad Noor, Shehzad Umara, Khan Faiz Ali, Loya Asif, Hamann Ute
Abstract excerpt
The Fanconi anemia complementation group M (FANCM) gene is a potential candidate for breast/ovarian cancer susceptibility in European populations. Here, we examined the contribution of FANCM germline variants to hereditary breast and/or ovarian cancer in Pakistan. Comprehensive FANCM variant screening was performed in 201 BRCA1 and BRCA2 (BRCA1/2) negative Pakistani patients with and without triple-negative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
